NYBC Ventures Overview

For Profit. For Purpose.

We are NYBC Ventures, the first venture fund solely dedicated to advancing innovation in blood-related and cellular medicines and technologies.

Our Areas of Interest

Taking an agnostic approach to financing vehicles and structures and employing a model of patient capital, we have developed streamlined scientific and investment due diligence teams to evaluate investment and collaborative opportunities in the following areas:

  • Benign hematology
  • Infectious diseases
  • Transfusion medicine
  • Cell therapy
  • Regenerative medicine

Capitalizing on New York Blood Center’s 50+ year history of providing high-quality, cutting-edge blood products and transfusion services to leading medical institutions, we leverage NYBC’s enterprise-wide leadership, infrastructure, resources, and unparalleled expertise and talent to explore and fund synergistic investment and collaborative opportunities:

Lindsley F. Kimball Research Institute (LFKRI)

Comprehensive Cell Solutions (CCS)

Connect with Us

To learn more about NYBC Ventures, please contact Meg Wood, Vice President of Ventures and Business Development.